Sitagliptin inhibits EndMT in vitro and improves cardiac function of diabetic rats through the SDF-1α/PKA pathway

Y. Wu; M. Xu; H. Bao; J.-H. Zhang

European review for medical and pharmacological sciences (2019) - Comments
pubmed: 30720193 doi: 10.26355/eurrev_201901_16899 issn: 1128-3602 issn: 2284-0729

Y. Wu, M. Xu, H. Bao, J.-H. Zhang

Go to article
Go to preprint

Verduci Editore s.r.l.